LDC has backed a management buyout of BioZone Scientific, facilitating the company's international expansion and growth in the UV technology market.
Information on the Target
BioZone Scientific is a prominent global manufacturer specializing in ultraviolet (UV) technology for disinfection, sanitation, and purification systems. Established over 25 years ago, the company has built a solid reputation as one of the leading developers of commercial-grade UV lighting solutions. With operations spanning five countries across the UK, Europe, Asia-Pacific, and North America, BioZone Scientific caters to a diverse clientele, including major multinational corporations in the leisure and transport sectors.
With a strong focus on innovation and quality, BioZone is strategically positioned to expand its international footprint. The company aims to accelerate its sales in the United States, open new offices in key locations, and invest in the development of next-generation UV products to meet growing global demand.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Target’s Specific Country
The UV technology industry has witnessed significant growth in recent years, driven by increased awareness of hygiene and disinfection practices worldwide, particularly in the wake of health crises such as the COVID-19 pand
Similar Deals
YFM → Audiological Science Limited
2024
Thompson Street Capital Partners → Absolute Antibody, Ltd.
2023
Bestport Private Equity → Hilditch Group Limited
2023
Catapult Venture Managers and The Co-operative Bank → Oxford Cryosystems Ltd.
2023
Lonsdale Capital Partners → Todays Dental Group Limited
2023
Tristone Healthcare → Beyond Limits (Plymouth) Ltd
2023
LDC
invested in
BioZone Scientific
in 2023
in a Management Buyout / Buy-In (MBO) deal